Resideo Technologies Quarterly Cash Flow Statements Chart
Quarterly
|
Annual
Resideo Technologies Quarterly Cash Flow Statements Table
Quarterly
|
Annual
| Unit: USD | 2025-06-28 | 2025-03-29 | 2024-12-31 | 2024-09-28 | 2024-06-29 | 2024-03-30 | 2023-12-31 | 2023-09-30 | 2023-07-01 | 2023-04-01 | 2022-12-31 | 2022-10-01 | 2022-07-02 | 2022-04-02 | 2021-12-31 | 2021-10-02 | 2021-07-03 | 2021-04-03 | 2020-12-31 | 2020-09-26 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| cash flows from operating activities: | |||||||||||||||||||||||||||
| net income | -825,000,000 | 6,000,000 | 23,000,000 | 20,000,000 | 30,000,000 | 43,000,000 | 82,000,000 | 21,000,000 | 50,000,000 | 57,000,000 | 39,000,000 | 63,000,000 | 94,000,000 | 87,000,000 | 67,000,000 | 68,000,000 | 58,000,000 | 49,000,000 | 59,000,000 | 75,000,000 | -76,000,000 | -21,000,000 | -9,000,000 | 8,000,000 | -11,000,000 | 48,000,000 | 16,000,000 |
| adjustments to reconcile net income to net cash in operating activities: | |||||||||||||||||||||||||||
| depreciation and amortization | 49,000,000 | 47,000,000 | 46,000,000 | 46,000,000 | 28,000,000 | 24,000,000 | 27,000,000 | 22,000,000 | 25,000,000 | 24,000,000 | 25,000,000 | 24,000,000 | 25,000,000 | 20,000,000 | 21,000,000 | 22,000,000 | 22,000,000 | 23,000,000 | 22,000,000 | 22,000,000 | 21,000,000 | 21,000,000 | 25,000,000 | 19,000,000 | 20,000,000 | 16,000,000 | |
| restructuring, impairment and extinguishment costs | 5,000,000 | ||||||||||||||||||||||||||
| stock-based compensation expense | 15,000,000 | 15,000,000 | 15,000,000 | 15,000,000 | 15,000,000 | 14,000,000 | 8,000,000 | 11,000,000 | 13,000,000 | 12,000,000 | |||||||||||||||||
| other | 2,000,000 | 6,000,000 | 2,000,000 | -12,000,000 | 14,000,000 | 3,000,000 | -16,000,000 | 0 | 0 | 2,000,000 | -2,000,000 | 13,000,000 | -7,000,000 | 2,000,000 | -1,000,000 | -14,000,000 | -7,000,000 | 25,000,000 | 1,000,000 | -1,000,000 | 9,000,000 | 12,000,000 | |||||
| changes in assets and liabilities, net of acquired companies: | |||||||||||||||||||||||||||
| accounts receivable | -72,000,000 | -13,000,000 | 61,000,000 | -22,000,000 | -91,000,000 | 34,000,000 | 28,000,000 | 26,000,000 | -58,000,000 | 23,000,000 | 70,000,000 | 3,000,000 | -84,000,000 | -61,000,000 | 48,000,000 | -45,000,000 | -16,000,000 | -17,000,000 | 37,000,000 | -177,000,000 | 130,000,000 | -17,000,000 | |||||
| inventories | -13,000,000 | 17,000,000 | -58,000,000 | -9,000,000 | -11,000,000 | 7,000,000 | 36,000,000 | 11,000,000 | 12,000,000 | -27,000,000 | 7,000,000 | -2,000,000 | -14,000,000 | -23,000,000 | -72,000,000 | -30,000,000 | |||||||||||
| other current assets | -35,000,000 | 9,000,000 | -20,000,000 | 6,000,000 | 6,000,000 | 3,000,000 | 11,000,000 | -8,000,000 | 11,000,000 | -8,000,000 | 12,000,000 | -17,000,000 | -9,000,000 | -12,000,000 | 33,000,000 | 18,000,000 | -40,000,000 | 16,000,000 | -10,000,000 | 2,000,000 | 3,000,000 | 10,000,000 | -40,000,000 | -5,000,000 | 8,000,000 | -16,000,000 | -23,000,000 |
| accounts payable | 109,000,000 | -101,000,000 | 65,000,000 | 31,000,000 | 75,000,000 | -44,000,000 | 32,000,000 | -58,000,000 | 56,000,000 | -12,000,000 | -48,000,000 | -49,000,000 | 37,000,000 | 17,000,000 | -23,000,000 | -4,000,000 | 0 | -15,000,000 | 61,000,000 | 47,000,000 | -108,000,000 | -1,000,000 | -15,000,000 | -48,000,000 | -45,000,000 | 70,000,000 | 80,000,000 |
| accrued liabilities | 185,000,000 | -112,000,000 | 69,000,000 | 13,000,000 | 11,000,000 | -89,000,000 | 80,000,000 | -20,000,000 | -8,000,000 | -86,000,000 | -29,000,000 | 22,000,000 | 19,000,000 | -66,000,000 | -12,000,000 | 36,000,000 | 56,000,000 | -66,000,000 | -17,000,000 | 40,000,000 | 88,000,000 | -80,000,000 | 28,000,000 | 11,000,000 | -11,000,000 | -6,000,000 | 80,000,000 |
| obligations payable under the indemnification agreement | |||||||||||||||||||||||||||
| net cash from operating activities | 200,000,000 | -65,000,000 | 203,000,000 | 147,000,000 | 92,000,000 | 2,000,000 | 263,000,000 | 60,000,000 | 121,000,000 | -4,000,000 | 139,000,000 | 37,000,000 | 35,000,000 | -59,000,000 | 112,000,000 | 104,000,000 | 94,000,000 | 5,000,000 | 152,000,000 | 21,000,000 | 145,000,000 | -74,000,000 | 93,000,000 | -33,000,000 | -27,000,000 | -10,000,000 | 87,000,000 |
| cash flows from investing activities: | |||||||||||||||||||||||||||
| acquisitions, net of cash acquired | -3,000,000 | 0 | 0 | -10,000,000 | 0 | -6,000,000 | -5,000,000 | -27,000,000 | |||||||||||||||||||
| capital expenditures | -20,000,000 | -31,000,000 | -22,000,000 | -22,000,000 | -15,000,000 | -21,000,000 | -31,000,000 | -25,000,000 | -29,000,000 | -20,000,000 | -51,000,000 | -10,000,000 | |||||||||||||||
| free cash flows | 180,000,000 | -96,000,000 | 181,000,000 | 125,000,000 | 77,000,000 | -19,000,000 | 232,000,000 | 35,000,000 | 92,000,000 | -24,000,000 | 88,000,000 | 27,000,000 | |||||||||||||||
| other investing activities | 2,000,000 | 0 | 7,000,000 | -1,000,000 | |||||||||||||||||||||||
| net cash from investing activities | -20,000,000 | -31,000,000 | -23,000,000 | -22,000,000 | -1,342,000,000 | -22,000,000 | 46,000,000 | -35,000,000 | -29,000,000 | -26,000,000 | -57,000,000 | -37,000,000 | -5,000,000 | -665,000,000 | -9,000,000 | -14,000,000 | -18,000,000 | -24,000,000 | -18,000,000 | -19,000,000 | -15,000,000 | -51,000,000 | -29,000,000 | -28,000,000 | -34,000,000 | -21,000,000 | -18,000,000 |
| cash flows from financing activities: | |||||||||||||||||||||||||||
| proceeds from issuance of long-term debt | 0 | ||||||||||||||||||||||||||
| proceeds from issuance of preferred stock, net of issuance costs | 0 | 0 | |||||||||||||||||||||||||
| repayments of long-term debt | -3,000,000 | -596,000,000 | -3,000,000 | -3,000,000 | -3,000,000 | -3,000,000 | -3,000,000 | -3,000,000 | -3,000,000 | -3,000,000 | |||||||||||||||||
| acquisition of treasury shares to cover stock award tax withholding | -1,000,000 | -15,000,000 | |||||||||||||||||||||||||
| preferred stock dividend payments | -8,000,000 | -9,000,000 | |||||||||||||||||||||||||
| other financing activities | 0 | 2,000,000 | 3,000,000 | -6,000,000 | -2,000,000 | -4,000,000 | -1,000,000 | 2,000,000 | -6,000,000 | -6,000,000 | |||||||||||||||||
| net cash from financing activities | -11,000,000 | -22,000,000 | -12,000,000 | -9,000,000 | 1,060,000,000 | -8,000,000 | -17,000,000 | -29,000,000 | -9,000,000 | -9,000,000 | -12,000,000 | -1,000,000 | -6,000,000 | 189,000,000 | -8,000,000 | 21,000,000 | -6,000,000 | 13,000,000 | 118,000,000 | -106,000,000 | -108,000,000 | 349,000,000 | -75,000,000 | 53,000,000 | -8,000,000 | -23,000,000 | 19,000,000 |
| effect of foreign exchange rate changes on cash, cash equivalents and restricted cash | 7,000,000 | 3,000,000 | -7,000,000 | 2,000,000 | 0 | -5,000,000 | -25,000,000 | -9,000,000 | 4,000,000 | 6,000,000 | 4,000,000 | ||||||||||||||||
| net increase in cash, cash equivalents and restricted cash | 161,000,000 | 118,000,000 | 267,000,000 | -13,000,000 | 74,000,000 | ||||||||||||||||||||||
| cash, cash equivalents and restricted cash at beginning of period | 0 | 693,000,000 | 0 | 0 | 637,000,000 | 0 | 0 | 329,000,000 | 0 | ||||||||||||||||||
| cash, cash equivalents and restricted cash at end of period | 176,000,000 | 578,000,000 | 118,000,000 | -190,000,000 | 604,000,000 | -13,000,000 | 87,000,000 | 296,000,000 | 0 | ||||||||||||||||||
| restructuring expenses | 4,000,000 | 7,000,000 | |||||||||||||||||||||||||
| obligations payable under indemnification agreements | 54,000,000 | 7,000,000 | -2,000,000 | 3,000,000 | 1,000,000 | -7,000,000 | 4,000,000 | ||||||||||||||||||||
| net decrease in cash, cash equivalents and restricted cash | -115,000,000 | -33,000,000 | -33,000,000 | ||||||||||||||||||||||||
| supplemental cash flow information: | |||||||||||||||||||||||||||
| interest paid, net of swaps | 39,000,000 | 21,000,000 | 19,000,000 | 16,000,000 | 22,000,000 | ||||||||||||||||||||||
| taxes paid, net of refunds | 21,000,000 | 46,000,000 | 28,000,000 | 60,000,000 | 28,000,000 | 19,000,000 | 37,000,000 | 48,000,000 | 19,000,000 | ||||||||||||||||||
| capital expenditures in accounts payable | 12,000,000 | 6,000,000 | 0 | 5,000,000 | 11,000,000 | -5,000,000 | -1,000,000 | 5,000,000 | 15,000,000 | ||||||||||||||||||
| deferred income taxes | -22,000,000 | -48,000,000 | |||||||||||||||||||||||||
| proceeds from sale of business | |||||||||||||||||||||||||||
| preferred dividend payments | |||||||||||||||||||||||||||
| common stock repurchases | 0 | -1,000,000 | -13,000,000 | ||||||||||||||||||||||||
| cash, cash equivalents and restricted cash at beginning of year | |||||||||||||||||||||||||||
| cash, cash equivalents and restricted cash at end of year | |||||||||||||||||||||||||||
| other liabilities | 20,000,000 | 5,000,000 | 7,000,000 | 7,000,000 | 5,000,000 | ||||||||||||||||||||||
| proceeds from issuance of incremental term loans under the a&r term b facility | |||||||||||||||||||||||||||
| restructuring and impairment expenses | 0 | 38,000,000 | |||||||||||||||||||||||||
| proceeds from issuance of a&r term b facility | 0 | 0 | |||||||||||||||||||||||||
| interest paid | -1,000,000 | 35,000,000 | 19,000,000 | 27,000,000 | 16,000,000 | 17,000,000 | |||||||||||||||||||||
| adjustments to reconcile net income to net cash from operating activities: | |||||||||||||||||||||||||||
| payment of debt facility issuance and modification costs | -4,000,000 | 0 | -18,000,000 | 0 | -21,000,000 | ||||||||||||||||||||||
| loss on extinguishment of debt | 0 | ||||||||||||||||||||||||||
| issuance of common stock through public offering, net of issuance costs | |||||||||||||||||||||||||||
| share-based compensation expense | 14,000,000 | ||||||||||||||||||||||||||
| changes in operating assets and liabilities, net of effect of acquisitions: | |||||||||||||||||||||||||||
| payments of debt facility issuance and modification costs | 0 | ||||||||||||||||||||||||||
| income taxes paid | 50,000,000 | -5,000,000 | |||||||||||||||||||||||||
| effect of foreign exchange rate changes on cash and cash equivalents | -2,000,000 | -4,000,000 | 1,000,000 | -3,000,000 | 5,000,000 | 2,000,000 | 2,000,000 | -8,000,000 | 1,000,000 | 1,000,000 | -7,000,000 | ||||||||||||||||
| net increase in cash and cash equivalents and restricted cash | |||||||||||||||||||||||||||
| stock compensation expense | 11,000,000 | 10,000,000 | 10,000,000 | 10,000,000 | 9,000,000 | 8,000,000 | 7,000,000 | 7,000,000 | 7,000,000 | 3,000,000 | 8,000,000 | 7,000,000 | 7,000,000 | 5,000,000 | |||||||||||||
| inventories – net | -66,000,000 | -33,000,000 | -32,000,000 | 2,000,000 | -10,000,000 | -45,000,000 | 6,000,000 | 64,000,000 | -6,000,000 | ||||||||||||||||||
| cash flows used for investing activities: | |||||||||||||||||||||||||||
| expenditures for property, plant, equipment and other intangibles | -19,000,000 | -15,000,000 | -13,000,000 | -16,000,000 | -19,000,000 | -20,000,000 | -19,000,000 | -15,000,000 | -16,000,000 | ||||||||||||||||||
| cash paid for acquisitions, net of cash acquired | -633,000,000 | 0 | -1,000,000 | -5,000,000 | -5,000,000 | 0 | 0 | 0 | -35,000,000 | 0 | 0 | -11,000,000 | -6,000,000 | ||||||||||||||
| proceeds from long-term debt | 200,000,000 | 0 | 300,000,000 | 0 | 950,000,000 | ||||||||||||||||||||||
| repayment of long-term debt | -3,000,000 | -3,000,000 | -262,000,000 | -2,000,000 | -921,000,000 | -11,000,000 | -5,000,000 | -11,000,000 | 0 | -5,000,000 | -6,000,000 | ||||||||||||||||
| net decrease in cash and cash equivalents | -535,000,000 | ||||||||||||||||||||||||||
| cash and cash equivalents at beginning of period | 779,000,000 | 0 | 0 | 517,000,000 | 0 | 0 | 0 | 122,000,000 | 0 | 0 | 0 | 265,000,000 | 0 | ||||||||||||||
| cash and cash equivalents at end of period | 244,000,000 | 107,000,000 | 71,000,000 | 508,000,000 | 257,000,000 | -102,000,000 | 24,000,000 | 338,000,000 | -10,000,000 | -10,000,000 | -70,000,000 | 212,000,000 | 81,000,000 | ||||||||||||||
| other assets | -9,000,000 | 2,000,000 | -7,000,000 | -1,000,000 | 2,000,000 | ||||||||||||||||||||||
| issuance of common stock through public offering, net of issuance cost | |||||||||||||||||||||||||||
| net increase in cash and cash equivalents | 93,000,000 | 107,000,000 | 71,000,000 | -9,000,000 | 257,000,000 | -102,000,000 | 24,000,000 | 216,000,000 | -10,000,000 | -10,000,000 | -70,000,000 | -53,000,000 | 81,000,000 | ||||||||||||||
| cash and cash equivalents at beginning of year | |||||||||||||||||||||||||||
| cash and cash equivalents at end of year | |||||||||||||||||||||||||||
| net proceeds from revolving credit facility | -100,000,000 | -100,000,000 | 350,000,000 | ||||||||||||||||||||||||
| cash flows from for investing activities: | |||||||||||||||||||||||||||
| distribution to honeywell in connection with spin-off | |||||||||||||||||||||||||||
| net increase in invested equity | |||||||||||||||||||||||||||
| non-operating obligations from honeywell | |||||||||||||||||||||||||||
| restructuring charges, net of payments | -2,000,000 | 1,000,000 | 5,000,000 | ||||||||||||||||||||||||
| changes in assets and liabilities: | |||||||||||||||||||||||||||
| non-operating obligations paid to honeywell | -1,000,000 | -6,000,000 | -3,000,000 | -15,000,000 | |||||||||||||||||||||||
| tax payments related to stock vestings | 0 | -1,000,000 | -1,000,000 | -1,000,000 | 0 | -2,000,000 | |||||||||||||||||||||
| obligations payable to honeywell under indemnification agreements | |||||||||||||||||||||||||||
| cash flows used for operating activities: | |||||||||||||||||||||||||||
| obligations payable to honeywell | -2,000,000 | 14,000,000 | -1,000,000 | 1,000,000 | -49,000,000 | ||||||||||||||||||||||
| accounts receivables | |||||||||||||||||||||||||||
| expenditures for property, plant, equipment and software | -29,000,000 | -28,000,000 | -23,000,000 | -15,000,000 | |||||||||||||||||||||||
| repositioning charges, net of payments | -2,000,000 | ||||||||||||||||||||||||||
| other noncash expense | 7,000,000 | 3,000,000 | 3,000,000 | ||||||||||||||||||||||||
| accounts, notes and other receivables | -20,000,000 | 10,000,000 | -17,000,000 | -51,000,000 | |||||||||||||||||||||||
| proceeds received related to amounts due from related parties | 0 | ||||||||||||||||||||||||||
| payments related to amounts due to related parties | |||||||||||||||||||||||||||
| net decrease in invested equity | |||||||||||||||||||||||||||
| cashflow provided by cash pooling | |||||||||||||||||||||||||||
| cash flows used for financing activities: | |||||||||||||||||||||||||||
| cashflow used by cash pooling | |||||||||||||||||||||||||||
| net cash flow used by cash pooling | |||||||||||||||||||||||||||
| depreciation | 5,000,000 | ||||||||||||||||||||||||||
| amortization | 12,000,000 | ||||||||||||||||||||||||||
| repositioning charges | |||||||||||||||||||||||||||
| net payments for repositioning charges | |||||||||||||||||||||||||||
| pension expense | 1,000,000 | ||||||||||||||||||||||||||
| pension obligations | |||||||||||||||||||||||||||
| expenditures for property, plant and equipment | -1,000,000 | ||||||||||||||||||||||||||
| expenditures for software | |||||||||||||||||||||||||||
| payments related to amounts due from related parties | |||||||||||||||||||||||||||
| payment of debt issuance costs | |||||||||||||||||||||||||||
| payment of revolving credit facility fees | |||||||||||||||||||||||||||
| net cash flow from (used by) cash pooling | |||||||||||||||||||||||||||
| repositioning | |||||||||||||||||||||||||||
| net payments for repositioning | |||||||||||||||||||||||||||
| bad debt expense | |||||||||||||||||||||||||||
| cash flows used in investing activities: | |||||||||||||||||||||||||||
| issuance related to amounts due from related parties | |||||||||||||||||||||||||||
| cash flows used in financing activities: | |||||||||||||||||||||||||||
| net (decrease) in invested equity | |||||||||||||||||||||||||||
| proceeds received related to amounts due to related parties | |||||||||||||||||||||||||||
| net cash flows from cash pooling |
We provide you with 20 years of cash flow statements for Resideo Technologies stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as operating cash flows, cash levels, capital expenditures, profits, stock-based compensations and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Resideo Technologies stock. Explore the full financial landscape of Resideo Technologies stock with our expertly curated income statements.
The information provided in this report about Resideo Technologies stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.